Company profile: EndNote Click
1.1 - Company Overview
Company description
- Provider of free web-based software and the EndNote Click browser plugin for fast, one-click access to academic journal articles and full-text PDFs, leveraging library subscriptions and open access alternatives to reach millions of research papers while reducing the need for VPNs, login forms, redirects, and chasing broken links.
Products and services
- EndNote Click: Browser-integrated plugin that delivers one-click access to full‑text PDFs of academic articles by utilizing library subscriptions and open access alternatives for streamlined retrieval
- Kopernio Web-Based Software: Free, web-based access tool enabling fast, one-click retrieval of academic journal articles and PDFs, removing VPNs, login forms, redirects, frantic Googling, and broken-link chasing
- One-Click Research Access: Fast, open-access-integrated service enabling one-click access to millions of research papers and PDFs while avoiding VPNs, login forms, redirects, frantic Googling, and broken links
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EndNote Click
IPM.ai
HQ: United States
Website
- Description: Provider of HIPAA-certified machine learning infrastructure for biopharma, delivering AI-powered patient finding, insights-as-a-service, and a system of insight using real-world data to optimize drug development and commercialization. Services include clinical study recruitment, market assessment, and patient journey mapping for specialty and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPM.ai company profile →
Formation Bio
HQ: United States
Website
- Description: Provider of a drug development platform and AI-driven tools to accelerate and optimize clinical trials and drug discovery. Offerings include an end-to-end platform leveraging proprietary technology, a clinical trial engine to improve recruitment, data collection and monitoring, and a universal data platform centralizing clinical data for rapid application creation and trial design.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Formation Bio company profile →
Cyrus
HQ: United States
Website
- Description: Provider of protein design software and services, including the Rosetta software combining physics-based modeling and statistical patterns to design protein binders, de novo proteins, and assemblies; the Cyrus software platform with Rosetta protocols, AI, cloud workflow automation, and in-house structure/data analysis; services for protein design, deep mutational scanning, cytokine engineering; and Next Gen IdeS enzyme for IgG-mediated disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cyrus company profile →
Invivodata
HQ: United States
Website
- Description: Provider of electronic patient-reported outcomes (ePRO) solutions and services for clinical trials, offering patient data collection, data management, and clinical outcome assessments software. Offers DiaryPRO electronic patient diary and DiaryPRO Web for PRO data collection via a web interface, and provides SitePRO, helping worldwide clinical trial sponsors assess the effectiveness of new medical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invivodata company profile →
Cryoport
HQ: United States
Website
- Description: Provider of outsourced temperature-controlled shipping and logistics for biological materials, offering ISO 21973-compliant shipping systems across cryogenic, ultra-cold (dry ice), refrigerated and controlled room temperatures; IntegriCell cryopreservation; integrated BioServices and biostorage; consulting to de-risk biologics and cell & gene therapy supply chains; and comprehensive upstream/downstream supply chain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoport company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EndNote Click
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EndNote Click
2.2 - Growth funds investing in similar companies to EndNote Click
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EndNote Click
4.2 - Public trading comparable groups for EndNote Click
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →